The Directorate-General for Internal Market, Industry, Entrepreneurship, and SMEs aims to guarantee a high level of protection of public health, contribute to the completion of the Single Market for Pharmaceuticals and Medical Devices, and foster a stable and predictable environment for innovation and competitiveness. It does this by identifying key issues that affect the competitiveness of the European healthcare industries and by proposing solutions in cooperation with stakeholders.
This Staff Working Document (204 KB) forms part of the European Commission’s efforts to contribute to growth and to foster the EU’s competitive role globally. It identifies policy areas where actions have already been undertaken and which could be explored further in the future. Specifically:
Commission Staff Working Document: “Pharmaceutical Industry: A Strategic Sector for the European Economy” (204 KB)
The European Commission monitors and analyses the competitiveness of the pharmaceutical industry through specialised studies carried out by external experts, informal or institutionalised contacts, and dialogue with public authorities and other stakeholders.
In early 2008, the Commission also launched an inquiry into competition in the pharmaceutical sector. Please visit the pharmaceuticals sector enquiry and follow-up webpage of the Directorate-General for Competition for more information.
Study on the competitiveness of the EU market and industry for pharmaceuticals
Studies which examine developments in the biosimilar and generic markets